Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug

2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.